Carl L. Gordon, Director, 10% Owner at Compass Therapeutics, Inc. (CMPX), bought 216,071 shares at $1.56 ($339K) on 2022-05-09, disclosed to the SEC on 2022-05-10.
Open-market purchase of $339k CMPX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.63 | 10,200 | $17K | 4.9% |
| 2 | $1.56 | 90,712 | $142K | 41.8% |
| 3 | $1.56 | 90,712 | $142K | 41.8% |
| 4 | $1.60 | 24,447 | $39K | 11.5% |
| Total | $1.57 avg | 216,071 | $339K | 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |